Darmstadt, Germany

Hans-Joachim Enenkel


Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 1978-1982

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Hans-Joachim Enenkel

Introduction

Hans-Joachim Enenkel is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of pharmaceuticals, holding a total of 6 patents. His work focuses on developing compounds that have important medical applications, particularly in lowering blood pressure.

Latest Patents

Among his latest patents, Enenkel has developed 13-Thiaprostaglandin derivatives, which are useful for lowering blood pressure and serve as intermediates for the preparation of other known pharmaceuticals. These compounds include 13-Thiaprostanoic acid derivatives characterized by a specific general formula, where various substituents play a crucial role in their pharmaceutical efficacy. Another notable patent involves 1-Aryloxy-3-nitratoalkylamino-2-propanols, which are utilized as beta-receptor compounds.

Career Highlights

Enenkel's career is marked by his association with Merck Patent Gesellschaft mit beschränkter Haftung, where he has been able to apply his innovative ideas in a collaborative environment. His work has not only advanced the field of pharmaceuticals but has also contributed to the development of new therapeutic agents.

Collaborations

Throughout his career, Enenkel has collaborated with esteemed colleagues such as Karl-Heinz Becker and Klaus Otto Minck. These partnerships have fostered a rich exchange of ideas and have led to the successful development of various pharmaceutical compounds.

Conclusion

Hans-Joachim Enenkel's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to impact medical science positively, paving the way for new treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…